Vivos Therapeutics, Inc. Current Income Tax Expense (Benefit)
Vivos Therapeutics, Inc. (VVOS) reported Current Income Tax Expense (Benefit) of -$12.06 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2021-03-25
- Vivos Therapeutics, Inc. current income tax expense (benefit) for fiscal 2020 was -$12.06M.
- Vivos Therapeutics, Inc. current income tax expense (benefit) for fiscal 2019 was -$10.75M.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2020-12-31 | -$12.06M 10-K · filed 2021-03-25 |
| 2019-12-31 | -$10.75M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |